Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan How

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Blood Advances|March 27, 2026
Exercise in MPNs: a promising first stepJoan How
Current Hematologic Malignancy Reports|September 3, 2021
Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia VeraJoan How, Gabriela Hobbs
Cancers|July 26, 2020
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the LiteratureJoan How, Gabriela Hobbs
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Interferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia VeraJoan How, Gabriela Hobbs
Hematology. American Society of Hematology. Education Program|December 7, 2024
Pregnancy: MPN management before, during, and after pregnancyJoan How, Gabriela Hobbs
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
A Practical Guide for Using Myelofibrosis Prognostic Models in the ClinicJoan How, Gabriela S Hobbs
Hematology. American Society of Hematology. Education Program|December 10, 2021
Blast and accelerated phase CML: room for improvementJoan How, Vinayak Venkataraman, Gabriela Soriano Hobbs
Postgraduate Medicine|January 22, 2021
Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulantsJoan How, Charlotte Story, Jean Marie Connors
Blood|September 29, 2019
Mutant calreticulin in myeloproliferative neoplasmsJoan How, Gabriela S Hobbs, Ann Mullally
Blood|December 19, 2022
Biology and therapeutic targeting of molecular mechanisms in MPNsJoan How, Jacqueline S Garcia, Ann Mullally
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Blood Advances|March 27, 2026
Exercise in MPNs: a promising first stepJoan How
Current Hematologic Malignancy Reports|September 3, 2021
Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia VeraJoan How, Gabriela Hobbs
Cancers|July 26, 2020
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the LiteratureJoan How, Gabriela Hobbs
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Interferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia VeraJoan How, Gabriela Hobbs
Hematology. American Society of Hematology. Education Program|December 7, 2024
Pregnancy: MPN management before, during, and after pregnancyJoan How, Gabriela Hobbs
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
A Practical Guide for Using Myelofibrosis Prognostic Models in the ClinicJoan How, Gabriela S Hobbs
Hematology. American Society of Hematology. Education Program|December 10, 2021
Blast and accelerated phase CML: room for improvementJoan How, Vinayak Venkataraman, Gabriela Soriano Hobbs
Postgraduate Medicine|January 22, 2021
Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulantsJoan How, Charlotte Story, Jean Marie Connors
Blood|September 29, 2019
Mutant calreticulin in myeloproliferative neoplasmsJoan How, Gabriela S Hobbs, Ann Mullally
Blood|December 19, 2022
Biology and therapeutic targeting of molecular mechanisms in MPNsJoan How, Jacqueline S Garcia, Ann Mullally
Pageof 5